Director · Terns Pharmaceuticals, Inc. · Common Stock
Side
SELL
Value
$441K
Shares
24.5K
Price
$18
Executed
Nov 4, 2025
Disclosed
Nov 5, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 4 executedNov 5, 2025 disclosed
TERN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Quigley Jill M. filed this Form 4 reporting a open-market sale of TERN on Nov 4, 2025. It became public on Nov 5, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Quigley Jill M.cik:0001799780
Issuer
Terns Pharmaceuticals, Inc.cik:0001831363
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for TERN is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
